Literature DB >> 35122601

SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.

Soo-Jin Oh1, Ok Sarah Shin2.   

Abstract

With global expansion of the COVID-19 pandemic and the emergence of new variants, extensive efforts have been made to develop highly effective antiviral drugs and vaccines against SARS-CoV-2. The interactions of coronaviruses with host antiviral interferon pathways ultimately determine successful viral replication and SARS-CoV-2-induced pathogenesis. Innate immune receptors play an essential role in host defense against SARS-CoV-2 via the induction of IFN production and signaling. Here, we summarize the recent advances in innate immune sensing mechanisms of SARS-CoV-2 and various strategies by which SARS-CoV-2 antagonizes antiviral innate immune signaling pathways, with a particular focus on mechanisms utilized by multiple SARS-CoV-2 proteins to evade interferon induction and signaling in host cell. Understanding the underlying immune evasion mechanisms of SARS-CoV-2 is essential for the improvement of vaccines and therapeutic strategies.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; immunity; interferon

Mesh:

Substances:

Year:  2022        PMID: 35122601      PMCID: PMC8817151          DOI: 10.1007/s12275-022-1525-1

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  89 in total

1.  The potential danger of suboptimal antibody responses in COVID-19.

Authors:  Akiko Iwasaki; Yexin Yang
Journal:  Nat Rev Immunol       Date:  2020-06       Impact factor: 53.106

2.  Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.

Authors:  Ke Zhang; Lisa Miorin; Tadashi Makio; Ishmael Dehghan; Shengyan Gao; Yihu Xie; Hualin Zhong; Matthew Esparza; Thomas Kehrer; Anil Kumar; Tom C Hobman; Christopher Ptak; Boning Gao; John D Minna; Zhijian Chen; Adolfo García-Sastre; Yi Ren; Richard W Wozniak; Beatriz M A Fontoura
Journal:  Sci Adv       Date:  2021-02-05       Impact factor: 14.136

3.  SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.

Authors:  Wenjing Wang; Zhuo Zhou; Xia Xiao; Zhongqin Tian; Xiaojing Dong; Conghui Wang; Li Li; Lili Ren; Xiaobo Lei; Zichun Xiang; Jianwei Wang
Journal:  Cell Mol Immunol       Date:  2021-02-26       Impact factor: 22.096

4.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

Review 5.  Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.

Authors:  Annsea Park; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2020-05-27       Impact factor: 21.023

6.  SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.

Authors:  Yujiro Toyoshima; Kensaku Nemoto; Saki Matsumoto; Yusuke Nakamura; Kazuma Kiyotani
Journal:  J Hum Genet       Date:  2020-07-22       Impact factor: 3.172

7.  Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.

Authors:  Theresa Klemm; Gregor Ebert; Dale J Calleja; Cody C Allison; Lachlan W Richardson; Jonathan P Bernardini; Bernadine Gc Lu; Nathan W Kuchel; Christoph Grohmann; Yuri Shibata; Zhong Yan Gan; James P Cooney; Marcel Doerflinger; Amanda E Au; Timothy R Blackmore; Gerbrand J van der Heden van Noort; Paul P Geurink; Huib Ovaa; Janet Newman; Alan Riboldi-Tunnicliffe; Peter E Czabotar; Jeffrey P Mitchell; Rebecca Feltham; Bernhard C Lechtenberg; Kym N Lowes; Grant Dewson; Marc Pellegrini; Guillaume Lessene; David Komander
Journal:  EMBO J       Date:  2020-08-26       Impact factor: 11.598

8.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

9.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Authors:  Paul Bastard; Lindsey B Rosen; Qian Zhang; Eleftherios Michailidis; Hans-Heinrich Hoffmann; Yu Zhang; Karim Dorgham; Quentin Philippot; Jérémie Rosain; Vivien Béziat; Steven M Holland; Guy Gorochov; Emmanuelle Jouanguy; Charles M Rice; Aurélie Cobat; Luigi D Notarangelo; Laurent Abel; Helen C Su; Jean-Laurent Casanova; Jérémy Manry; Elana Shaw; Liis Haljasmägi; Pärt Peterson; Lazaro Lorenzo; Lucy Bizien; Sophie Trouillet-Assant; Kerry Dobbs; Adriana Almeida de Jesus; Alexandre Belot; Anne Kallaste; Emilie Catherinot; Yacine Tandjaoui-Lambiotte; Jeremie Le Pen; Gaspard Kerner; Benedetta Bigio; Yoann Seeleuthner; Rui Yang; Alexandre Bolze; András N Spaan; Ottavia M Delmonte; Michael S Abers; Alessandro Aiuti; Giorgio Casari; Vito Lampasona; Lorenzo Piemonti; Fabio Ciceri; Kaya Bilguvar; Richard P Lifton; Marc Vasse; David M Smadja; Mélanie Migaud; Jérome Hadjadj; Benjamin Terrier; Darragh Duffy; Lluis Quintana-Murci; Diederik van de Beek; Lucie Roussel; Donald C Vinh; Stuart G Tangye; Filomeen Haerynck; David Dalmau; Javier Martinez-Picado; Petter Brodin; Michel C Nussenzweig; Stéphanie Boisson-Dupuis; Carlos Rodríguez-Gallego; Guillaume Vogt; Trine H Mogensen; Andrew J Oler; Jingwen Gu; Peter D Burbelo; Jeffrey I Cohen; Andrea Biondi; Laura Rachele Bettini; Mariella D'Angio; Paolo Bonfanti; Patrick Rossignol; Julien Mayaux; Frédéric Rieux-Laucat; Eystein S Husebye; Francesca Fusco; Matilde Valeria Ursini; Luisa Imberti; Alessandra Sottini; Simone Paghera; Eugenia Quiros-Roldan; Camillo Rossi; Riccardo Castagnoli; Daniela Montagna; Amelia Licari; Gian Luigi Marseglia; Xavier Duval; Jade Ghosn; John S Tsang; Raphaela Goldbach-Mansky; Kai Kisand; Michail S Lionakis; Anne Puel; Shen-Ying Zhang
Journal:  Science       Date:  2020-09-24       Impact factor: 63.714

View more
  3 in total

1.  Two years of COVID-19 pandemic: where are we now?

Authors:  Jinjong Myoung
Journal:  J Microbiol       Date:  2022-03       Impact factor: 3.422

2.  Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.

Authors:  Nan Xu; Jinjin Pan; Li Sun; Cuimei Zhou; Siran Huang; Mingwei Chen; Junfei Zhang; Tiantian Zhu; Jiabin Li; Hong Zhang; Yufeng Gao
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

Review 3.  SARS-CoV-2: A Master of Immune Evasion.

Authors:  Alberto Rubio-Casillas; Elrashdy M Redwan; Vladimir N Uversky
Journal:  Biomedicines       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.